Oculopharyngeal Muscular Dystrophy Clinical Trial
— NH-OPMDOfficial title:
Natural History Study of Oculopharyngeal Muscular Dystrophy
| NCT number | NCT03161847 |
| Other study ID # | 16-326 |
| Secondary ID | |
| Status | Withdrawn |
| Phase | |
| First received | |
| Last updated | |
| Start date | December 12, 2016 |
| Est. completion date | July 18, 2018 |
| Verified date | May 2017 |
| Source | University of New Mexico |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
The objective of this study is to test a set of clinical outcome measures longitudinally in a cohort of OPMD patients to identify ones that show quantifiable change over time as the disease progresses. The investigators' goal is to delineate the natural history of OPMD.
| Status | Withdrawn |
| Enrollment | 0 |
| Est. completion date | July 18, 2018 |
| Est. primary completion date | July 18, 2018 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 99 Years |
| Eligibility | Inclusion Criteria: - OPMD by genetic criteria - = 18 years old - English-speaking Exclusion Criteria: - Another medical condition that precludes safe completion of study tasks (such as severe cardiac or respiratory disease) - Another medical condition that causes symptoms similar to OPMD (i.e., ptosis, dysphagia [trouble swallowing] or limb weakness). - History of head or neck cancer, or history of radiation to the head or neck - A videofluoroscopic swallow study within the 12 months prior to study enrollment |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| University of New Mexico | University of Florida |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Muscle Strength over time | Change in Manual muscle testing over time | Baseline and every 9 months for 3 years | |
| Secondary | Dysphagia severity over time | Videofluoroscopic Swallow Studies | Baseline and every 9 months for 3 years |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02877784 -
Screening in Oculopharyngeal Muscular Dystrophy
|
||
| Recruiting |
NCT06185673 -
A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia
|
Phase 1/Phase 2 | |
| Enrolling by invitation |
NCT04009408 -
Expiratory Muscle Strength Training (EMST) in Neuromuscular Disorders
|
N/A | |
| Recruiting |
NCT03874910 -
Pathology Analysis of OPMD Patient Myotomies
|
||
| Withdrawn |
NCT04226924 -
Treatment of Oculopharyngeal Muscular Dystrophy With Trehalose
|
Phase 2 | |
| Recruiting |
NCT02158156 -
Effect of Aerobic Training in Patients With Oculopharyngeal Muscular Dystrophy
|
N/A | |
| Completed |
NCT02015481 -
Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients
|
Phase 2 |